Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23902488 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Conditions: Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis
Interventions: Drug: Rituximab plus cyclophosphamide placebo (rituximab group);   Drug: Cyclophosphamide plus rituximab placebo (control group);   Drug: Azathioprine;   Drug: Methylprednisolone (or other glucocorticoid);   Drug: Prednisone

Indicates status has not been verified in more than two years